Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-08-16 Purchase | 2023-08-16 8:52 pm | Taysha Gene Therapies Inc. | TSHA | Nolan Sean P. Chief Executive Officer | 444,444 | $0.9 | $400,000 | 1,536,715 (Indirect Direct) | View |
| 2021-05-20 Purchase | 2021-05-24 08:39 am | Taysha Gene Therapies Inc. | TSHA | Nolan Sean P. Director | 1,170 | $22.35 | $26,150 | 1,092,271 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-05-14 Option Award | 2024-05-16 5:01 pm | N/A N/A | Ventas Inc. | VTR | Nolan Sean P. Director | 3,648 | $47.96 | 21,252 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 4:41 pm | N/A 2034-01-02 | Taysha Gene Therapies Inc. | TSHA | Nolan Sean P. Chief Executive Officer | 1,184,688 | $0 | 3,906,091 (Direct) | View |
| 2023-12-14 Option Award | 2023-12-18 4:46 pm | N/A 2033-12-14 | Taysha Gene Therapies Inc. | TSHA | Nolan Sean P. Chief Executive Officer | 466,550 | $0 | 466,550 (Direct) | View |
| 2023-05-16 Option Award | 2023-05-18 4:48 pm | N/A N/A | Ventas Inc. | VTR | Nolan Sean P. Director | 3,835 | $45.63 | 17,604 (Direct) | View |
| 2022-12-30 Option Award | 2023-01-04 4:51 pm | N/A 2032-12-30 | Taysha Gene Therapies Inc. | TSHA | Nolan Sean P. Chief Executive Officer | 1,106,131 | $0 | 1,106,131 (Direct) | View |
| 2022-06-17 Option Award | 2022-06-22 4:38 pm | N/A 2032-06-17 | Taysha Gene Therapies Inc. | TSHA | Nolan Sean P. Director | 15,500 | $0 | 15,500 (Direct) | View |
| 2022-04-27 Option Award | 2022-04-29 4:50 pm | N/A N/A | Ventas Inc. | VTR | Nolan Sean P. Director | 3,056 | $57.25 | 13,769 (Direct) | View |
| 2021-06-17 Option Award | 2021-06-21 5:02 pm | N/A 2031-06-17 | Taysha Gene Therapies Inc. | TSHA | Nolan Sean P. Director | 15,500 | $0 | 15,500 (Direct) | View |
| 2021-05-25 Option Award | 2021-05-27 5:28 pm | N/A N/A | Ventas Inc. | VTR | Nolan Sean P. Director | 3,158 | $0 | 10,713 (Direct) | View |
| 2020-09-28 Conversion | 2020-09-30 4:38 pm | N/A N/A | Taysha Gene Therapies Inc. | TSHA | Nolan Sean P. Director | 2,092,571 | $0 | 1,091,101 (Indirect) | View |
| 2020-09-23 Option Award | 2020-09-25 5:13 pm | N/A 2030-09-23 | Taysha Gene Therapies Inc. | TSHA | Nolan Sean P. Director | 31,000 | $0 | 31,000 (Direct) | View |
Ownership | 2020-09-23 8:29 pm | N/A N/A | Taysha Gene Therapies Inc. | TSHA | Nolan Sean P. Director | 0 | $0 | 1,091,101 (Indirect) | View |
| 2020-05-18 Option Award | 2020-05-20 4:53 pm | N/A N/A | Ventas Inc. | VTR | Nolan Sean P. Director | 5,424 | $0 | 7,555 (Direct) | View |
| 2020-05-05 Option Award | 2020-05-07 4:25 pm | N/A 2030-05-05 | Neoleukin Therapeutics Inc. | NLTX | Nolan Sean P. Director | 25,000 | $0 | 25,000 (Direct) | View |